+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atracurium Market - Global Forecast 2026-2032- Product Image
Atracurium Market - Global Forecast 2026-2032- Product Image
Sale

Atracurium Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6013935
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Atracurium Market is projected to reach USD 267.17 Million in 2026. It is expected to continue growing at a CAGR of 4.28%, reaching USD 337.73 Million by 2032.

Atracurium: Clinical Role and Executive Overview

Atracurium is a nondepolarizing neuromuscular-blocking medicine used as an adjunct to general anesthesia to facilitate tracheal intubation and provide skeletal-muscle relaxation during surgery or controlled ventilation. Its organ-independent Hofmann elimination can be clinically relevant when renal or hepatic function is impaired, although dosing and monitoring remain essential. This executive summary examines the treatment’s clinical positioning, operating environment, regional variation, stakeholder priorities, and evidence requirements without presenting market estimates or forecasts.

Clinical Practice Is Shifting Toward Precision and Monitoring

The atracurium landscape is being shaped by stronger emphasis on individualized dosing, quantitative neuromuscular monitoring, rapid recovery, and medication-safety controls. Operating-room protocols increasingly distinguish between routine procedures and patients with comorbidities, while anesthesia teams balance onset, duration, metabolism, hemodynamic tolerance, and reversal strategies. Supply continuity, standardized preparation, and adherence to labeling and institutional formularies also remain important because neuromuscular blockade requires trained administration and airway-support capability.

Artificial Intelligence Supports Safer Perioperative Workflows

Artificial intelligence can contribute to atracurium-related care through prediction of difficult airways, automated interpretation of neuromuscular-monitoring signals, dose-support tools, and detection of delayed recovery patterns. Its value is cumulative when integrated with electronic anesthesia records, pharmacy controls, and postoperative surveillance rather than used as an autonomous prescribing mechanism. Validation across patient populations, transparent model performance, cybersecurity, human oversight, and compliance with medical-device and clinical-governance requirements are necessary before routine deployment.

Regional Differences Reflect Access, Protocols, and Perioperative Capacity

In North America, use is supported by advanced anesthesia services, monitoring adoption, and formal medication-safety programs. Europe emphasizes guideline alignment, pharmacovigilance, and harmonized quality expectations, while Asia-Pacific combines sophisticated tertiary-care capacity with substantial variation in access across health systems. Latin America is influenced by public-sector procurement, import dependence, and uneven availability of trained anesthesia personnel. The Middle East shows concentration of advanced surgical services in major centers, and Africa faces wider constraints involving workforce, critical-care infrastructure, procurement reliability, and monitoring availability.

Regional and Economic Blocs Shape Procurement and Standards

ASEAN markets differ in regulatory maturity, hospital capability, and dependence on imported medicines, making local registration and supply planning important. BRICS members span large and diverse healthcare systems where domestic production, public procurement, and tertiary-care access can strongly influence availability. The European Union benefits from coordinated regulatory structures while retaining national reimbursement and purchasing decisions. G7 systems generally have stronger perioperative infrastructure and monitoring capacity. GCC countries often combine centralized procurement with high-acuity hospital development, while NATO members may additionally prioritize resilient pharmaceutical supply chains and continuity of critical-care capability.

Country Contexts Require Localized Clinical and Supply Strategies

Australia and Canada emphasize hospital protocols, workforce capability, and reliable distribution across geographically dispersed systems. Brazil, Mexico, India, China, Russia, and South Korea combine major tertiary-care centers with regional variation in procurement, regulation, and monitoring access. France, Germany, Italy, Spain, and the United Kingdom operate within mature anesthesia environments shaped by national or regional formularies, pharmacovigilance, and healthcare procurement. Across the United States and these countries, institutional adoption depends on clinical preference, availability of alternatives, labeling, supply continuity, and the ability to support quantitative neuromuscular monitoring and reversal practices.

Prioritize Safety, Evidence, and Supply Resilience

Industry leaders should maintain robust quality systems, dual-source critical inputs where feasible, and clear shortage-response procedures. Clinical education should focus on patient selection, dosing discipline, airway readiness, quantitative monitoring, recognition of adverse reactions, and complete recovery before extubation. Evidence programs should evaluate real-world safety, use in organ dysfunction, pediatric and older populations where applicable, and workflow outcomes without overstating comparative benefits. Digital initiatives should remain clinician-supervised, interoperable, privacy-preserving, and prospectively validated. Engagement with regulators, hospitals, professional societies, and procurement authorities can support responsible access and consistent practice.

Methodology: Evidence-Based Clinical and Health-System Synthesis

This executive summary uses a structured qualitative review framework focused on atracurium’s labeled clinical role, pharmacologic characteristics, anesthesia practice, safety considerations, health-system access, and regulatory context. Insights are organized across the specified regions, country groupings, and countries, with emphasis on verifiable clinical and operational themes rather than numerical market measures. Interpretation should be refreshed against current product labeling, clinical guidelines, regulatory notices, pharmacovigilance findings, hospital protocols, and independently validated studies before informing investment, procurement, or treatment decisions.

Atracurium Remains Relevant Where Controlled Neuromuscular Blockade Is Needed

Atracurium’s continued clinical relevance rests on its established role in anesthesia and its organ-independent elimination pathway, balanced against the need for skilled administration, airway support, and objective recovery monitoring. Regional and national differences in infrastructure, procurement, regulation, and clinical training will continue to shape practical use. The strongest strategies combine dependable quality and supply with evidence-based protocols, responsible digital support, and patient-centered perioperative governance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Atracurium Market, by Form
7.1. Introduction
7.2. Lyophilized Powder
7.2.1. Multi Dose Vial
7.2.2. Single Dose Vial
7.3. Pre-Filled Syringe
8. Atracurium Market, by Route Of Administration
8.1. Introduction
8.2. Intravenous
8.2.1. Bolus Injection
8.2.2. Continuous Infusion
9. Atracurium Market, by Application
9.1. Introduction
9.2. Intensive Care
9.2.1. Diagnostic Procedures
9.2.2. Mechanical Ventilation
9.3. Surgical Procedures
9.3.1. Cardiovascular Surgery
9.3.2. General Surgery
9.3.3. Neurological Surgery
9.3.4. Orthopedic Surgery
10. Atracurium Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.2.1. Hospital Affiliated Centers
10.2.2. Standalone Centers
10.3. Clinics
10.3.1. General Clinics
10.3.2. Specialty Clinics
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Atracurium Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. In-House Pharmacy
11.2.2. Outsourced Pharmacy
11.3. Online Pharmacies
11.3.1. Otc Pharmacies
11.3.2. Prescription Pharmacies
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Atracurium Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Atracurium Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Atracurium Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alkaloids Corporation
16.2. Baxter Healthcare
16.3. CF Pharma Ltd.
16.4. Eugia Pharma
16.5. Gland Pharma Limited
16.6. GlaxoSmithKline
16.7. Global Calcium
16.8. Hikma Pharmaceuticals
16.9. Hospira
16.10. Meitheal Pharmaceuticals
16.11. Neon Laboratories Ltd.
16.12. Shandong Boyuan Pharmaceutical Co., Ltd.
16.13. Synnat Pharma
16.14. Teva Pharmaceutical Industries
16.15. Teva Pharmaceutical Industries Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Atracurium Market, Years Considered for the Study
FIGURE 2. Global Atracurium Market, Research Design
FIGURE 3. Global Atracurium Market, Research Framework
FIGURE 4. Global Atracurium Market, Data Triangulation
FIGURE 5. Global Atracurium Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Atracurium Market Size, by Form, 2025 vs 2032 (%)
FIGURE 7. Global Atracurium Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Atracurium Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Atracurium Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Atracurium Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Atracurium Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Atracurium Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Atracurium Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Atracurium Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Atracurium Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Atracurium Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Atracurium Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Atracurium Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Atracurium Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Atracurium Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Atracurium Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Atracurium Market Segmentation & Coverage
TABLE 2. Global Atracurium Market Size, 2017-2032 (USD Million)
TABLE 3. Global Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 4. Global Lyophilized Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Lyophilized Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Lyophilized Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Multi Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Multi Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Multi Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Single Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Single Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Single Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pre-Filled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pre-Filled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pre-Filled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 17. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Bolus Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Bolus Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Bolus Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Continuous Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Continuous Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Continuous Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 27. Global Intensive Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Intensive Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Intensive Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Diagnostic Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Diagnostic Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Diagnostic Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Mechanical Ventilation Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Mechanical Ventilation Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Mechanical Ventilation Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Surgical Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Surgical Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Surgical Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Cardiovascular Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Cardiovascular Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Cardiovascular Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global General Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global General Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global General Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Neurological Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Neurological Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Neurological Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Orthopedic Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Orthopedic Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Orthopedic Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 52. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Hospital Affiliated Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Hospital Affiliated Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Hospital Affiliated Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Standalone Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Standalone Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Standalone Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global General Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global General Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global General Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global In-House Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global In-House Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global In-House Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Outsourced Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Outsourced Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Outsourced Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Otc Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Otc Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Otc Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Prescription Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Prescription Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Prescription Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Chain Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Chain Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Chain Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Independent Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Independent Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Independent Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Atracurium Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Atracurium Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 124. North America Atracurium Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. North America Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 126. North America Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 127. North America Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 128. North America Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 129. North America Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. North America Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 131. North America Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 132. North America Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. North America Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 134. North America Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 135. North America Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 136. North America Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. North America Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 138. North America Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 139. North America Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 140. Latin America Atracurium Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Latin America Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 142. Latin America Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 143. Latin America Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 144. Latin America Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 145. Latin America Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Latin America Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 147. Latin America Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 148. Latin America Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Latin America Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 150. Latin America Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 151. Latin America Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 152. Latin America Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Latin America Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 154. Latin America Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 155. Latin America Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 156. Europe Atracurium Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Europe Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 158. Europe Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 159. Europe Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 160. Europe Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 161. Europe Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Europe Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 163. Europe Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 164. Europe Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Europe Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 166. Europe Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 167. Europe Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 168. Europe Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. Europe Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 170. Europe Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 171. Europe Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 172. Middle East Atracurium Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Middle East Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 174. Middle East Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 175. Middle East Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 176. Middle East Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 177. Middle East Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Middle East Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 179. Middle East Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 180. Middle East Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Middle East Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 182. Middle East Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 183. Middle East Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 184. Middle East Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. Middle East Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 186. Middle East Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 187. Middle East Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 188. Africa Atracurium Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Africa Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 190. Africa Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 191. Africa Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 192. Africa Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 193. Africa Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Africa Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 195. Africa Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 196. Africa Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Africa Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 198. Africa Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 199. Africa Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 200. Africa Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. Africa Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 202. Africa Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 203. Africa Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 204. Global Atracurium Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. ASEAN Atracurium Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. ASEAN Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 207. ASEAN Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 208. ASEAN Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 209. ASEAN Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 210. ASEAN Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. ASEAN Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 212. ASEAN Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 213. ASEAN Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. ASEAN Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 215. ASEAN Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 216. ASEAN Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 217. ASEAN Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. ASEAN Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 219. ASEAN Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 220. ASEAN Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 221. GCC Atracurium Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. GCC Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 223. GCC Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 224. GCC Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 225. GCC Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 226. GCC Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. GCC Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 228. GCC Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 229. GCC Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. GCC Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 231. GCC Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 232. GCC Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 233. GCC Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. GCC Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 235. GCC Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 236. GCC Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 237. European Union Atracurium Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. European Union Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 239. European Union Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 240. European Union Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 241. European Union Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 242. European Union Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. European Union Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 244. European Union Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 245. European Union Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. European Union Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 247. European Union Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 248. European Union Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 249. European Union Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. European Union Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 251. European Union Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 252. European Union Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 253. BRICS Atracurium Market Size, by Group, 2017-2032 (USD Million)
TABLE 254. BRICS Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 255. BRICS Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 256. BRICS Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 257. BRICS Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 258. BRICS Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. BRICS Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 260. BRICS Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 261. BRICS Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. BRICS Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 263. BRICS Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 264. BRICS Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 265. BRICS Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. BRICS Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 267. BRICS Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 268. BRICS Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 269. G7 Atracurium Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. G7 Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 271. G7 Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 272. G7 Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 273. G7 Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 274. G7 Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. G7 Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 276. G7 Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 277. G7 Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. G7 Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 279. G7 Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 280. G7 Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 281. G7 Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. G7 Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 283. G7 Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 284. G7 Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 285. NATO Atracurium Market Size, by Group, 2017-2032 (USD Million)
TABLE 286. NATO Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 287. NATO Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 288. NATO Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 289. NATO Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 290. NATO Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. NATO Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 292. NATO Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 293. NATO Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. NATO Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 295. NATO Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 296. NATO Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 297. NATO Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 298. NATO Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 299. NATO Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 300. NATO Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 301. Global Atracurium Market Size, by Country, 2017-2032 (USD Million)
TABLE 302. United States Atracurium Market Size, 2017-2032 (USD Million)
TABLE 303. United States Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 304. United States Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 305. United States Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 306. United States Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 307. United States Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. United States Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 309. United States Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 310. United States Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. United States Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 312. United States Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 313. United States Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 314. United States Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 315. United States Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 316. United States Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 317. United States Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 318. Canada Atracurium Market Size, 2017-2032 (USD Million)
TABLE 319. Canada Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 320. Canada Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 321. Canada Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 322. Canada Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 323. Canada Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. Canada Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 325. Canada Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 326. Canada Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 327. Canada Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 328. Canada Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 329. Canada Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 330. Canada Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 331. Canada Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 332. Canada Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 333. Canada Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 334. Mexico Atracurium Market Size, 2017-2032 (USD Million)
TABLE 335. Mexico Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 336. Mexico Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 337. Mexico Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 338. Mexico Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 339. Mexico Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 340. Mexico Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 341. Mexico Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 342. Mexico Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 343. Mexico Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 344. Mexico Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 345. Mexico Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 346. Mexico Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 347. Mexico Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 348. Mexico Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 349. Mexico Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 350. Brazil Atracurium Market Size, 2017-2032 (USD Million)
TABLE 351. Brazil Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 352. Brazil Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 353. Brazil Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 354. Brazil Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 355. Brazil Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 356. Brazil Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 357. Brazil Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 358. Brazil Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 359. Brazil Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 360. Brazil Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 361. Brazil Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 362. Brazil Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 363. Brazil Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 364. Brazil Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 365. Brazil Atracurium Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 366. United Kingdom Atracurium Market Size, 2017-2032 (USD Million)
TABLE 367. United Kingdom Atracurium Market Size, by Form, 2017-2032 (USD Million)
TABLE 368. United Kingdom Atracurium Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 369. United Kingdom Atracurium Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 370. United Kingdom Atracurium Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 371. United Kingdom Atracurium Market Size, by Application, 2017-2032 (USD Million)
TABLE 372. United Kingdom Atracurium Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 373. United Kingdom Atracurium Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 374. United Kingdom Atracurium Market Size, by End User, 2017-2032 (USD Million)
TABLE 375. United Kingdom Atracurium Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 376. United Kingdom Atracurium Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 377. United Kingdom Atracurium Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 378. United Kingdom Atracurium Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 379. United Kingdom Atracurium Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 380. United Kingdom Atracurium Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 381. United Kingdom Atracurium Market Size, by Retail Pharmacies, 2017-2032 (US

Companies Mentioned

  • Alkaloids Corporation
  • Baxter Healthcare
  • CF Pharma Ltd.
  • Eugia Pharma
  • Gland Pharma Limited
  • GlaxoSmithKline
  • Global Calcium
  • Hikma Pharmaceuticals
  • Hospira
  • Meitheal Pharmaceuticals
  • Neon Laboratories Ltd.
  • Shandong Boyuan Pharmaceutical Co., Ltd.
  • Synnat Pharma
  • Teva Pharmaceutical Industries
  • Teva Pharmaceutical Industries Ltd.

Related Topics

Related Reports

Atracurium Besylate (CAS 64228-81-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Atracurium Besylate (CAS 64228-81-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Cisatracurium Besilate Injection Market - Global Forecast 2026-2032 - Product Image

Cisatracurium Besilate Injection Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Anesthetic Drugs Market - Global Forecast 2026-2032 - Product Image

Anesthetic Drugs Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
General Anesthesia Drugs - Global Strategic Business Report - Product Image

General Anesthesia Drugs - Global Strategic Business Report

  • Report
  • 379 Pages
  • Global
From
Anesthesia Information Management Systems - Global Strategic Business Report - Product Image

Anesthesia Information Management Systems - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From

About the Atracurium Market

Atracurium is a neuromuscular blocking drug used in anesthetic drugs. It is a synthetic, short-acting, non-depolarizing muscle relaxant that is used to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is also used to reduce the amount of anesthetic drugs needed during surgery. Atracurium is metabolized by the enzyme pseudocholinesterase, which is found in the plasma and liver. Atracurium is available in a variety of formulations, including injection, infusion, and inhalation. It is typically administered intravenously, but can also be administered intramuscularly or subcutaneously. The drug is available in both generic and branded forms. The Atracurium market is highly competitive, with several major players in the market. Some of the major companies in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.